BRO vs LPLA

The Advanced Deterministic Scorecard reveals a mixed health profile with a weak Piotroski F-Score of 4/9, indicating borderline financial stability, and no available Altman Z-Score to assess bankruptcy risk. Despite strong revenue growth of 34.20% and solid profitability metrics like a 27.36% operating margin, earnings have declined YoY by -16.10%, creating a divergence between top-line and bottom-line performance. The stock trades above its Graham Number of $52.48 at $79.18, reflecting a premium valuation supported by growth expectations and sector outperformance in revenue. Analysts concur with a 'hold' recommendation, while insider sentiment is neutral and technical indicators suggest bearish momentum.

LPLA exhibits a stable financial foundation with a Piotroski F-Score of 5/9, though it currently trades at a significant premium to its Graham Number ($128.01) and Intrinsic Value ($151.65). The company demonstrates elite operational consistency, having beaten earnings estimates for nearly 25 consecutive quarters, and possesses a highly attractive PEG ratio of 0.42. However, the valuation gap, combined with bearish insider selling and a 0/100 technical trend, offsets the strong growth metrics. The stock appears to be a high-quality compounder that is currently overpriced based on deterministic value models but potentially undervalued based on forward-looking growth projections.